CLINICAL_TRIALS
trial_result
· 2012-06-21
Clinical Trial Update: 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection [Phase 2]
Summary
A Phase 2 48-week study in pediatric HIV patients comparing GW433908 with ritonavir versus GW433908 alone; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus I | Phase 2 | Status: COMPLETED | Results posted: 2012-06-21